T. Iga

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
T Iga, T. Iga, Tatsuji Iga
Publication record
421 papers · 6,307 citations · H-index 40

PAPERS

Comparative study of effects of angiotensin II receptor antagonist, KD3-671, and angiotensin converting enzyme inhibitor, enalaprilat, on cough reflex in guinea pig
20103 citationsauthor #7
Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects.
20076 citationsauthor #5
Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler.
200719 citationsauthor #4
[Analysis of antiemetic effect of various dosage regimens of azasetron hydrochloride based on 5-HT3 receptor occupancy of serotonin].
20074 citationsauthor #7
Relationship between amount of drug delivered to lungs and amount released from Diskhaler by inhalation with tapping.
20074 citationsauthor #6
Kinetic analysis of effects of mouth washing on removal of drug residues following inhalation of fluticasone propionate dry powder.
20074 citationsauthor #4
Frequency Distribution of CYP 2 C 19 , CYP 2 D 6 , and CYP 2 C 9 Mutant-alleles in Several Different Populations
20072 citationsauthor #3
Dispensing Techniques Seminar Held for Hospital and Community Pharmacy Pharmacists and its Evaluation
20070 citationsauthor #11
Development of Training System for New Pharmacists using Actual Prescriptions, and its Evaluation
20071 citationsauthor #8
Effects of mouth washing procedures on removal of budesonide inhaled by using Turbuhaler.
20073 citationsauthor #4
Influence of mouth washing procedures on the removal of drug residues following inhalation of corticosteroids.
200612 citationsauthor #4
Analysis of Relationship between Peak Inspiratory Flow Rate and Amount of Drug Delivered to Lungs Following Inhalation of Fluticasone Propionate with a
20060 citationsauthor #4
Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.
200671 citationsauthor #7
[Analysis of the factors associated with drugs remaining in the Diskhaler following inhalation of fluticasone propionate].
20063 citationsauthor #5
Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem.
200519 citationsauthor #8
High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction.
200546 citationsauthor #7
Developments in Pharmaceutical Science Achieved by University Hospital Pharmacy Department in Last 15 Years
20051 citationsauthor #1
Corrigendum to “High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction” [Anal. Biochem. 337 (2005) 256–261]
20051 citationsauthor #7
Investigation of mouth washing by patients after inhaling corticosteroids.
20058 citationsauthor #4
Development and evaluation of pharmaceutical services in the ICU/CCU by medical staffs.
20046 citationsauthor #7
Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
200440 citationsauthor #12
A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype.
200419 citationsauthor #4
Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by rhG-CSF in patients receiving antineoplastic drugs.
20045 citationsauthor #5
Stereospecific Distribution of Methylphenidate Enantiomers in Rat Brain: Specific Binding to Dopamine Reuptake Sites
20048 citationsauthor #4
Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
200426 citationsauthor #5
Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers
200421 citationsauthor #6
The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers
200414 citationsauthor #5
Effect of particle size on mixing degree in dispensation.
20044 citationsauthor #8
The Effects of Indomethacin Spray on the Pain of Stomatitis in the Patients for Hematopoietic Stem Cell Transplantation
20040 citationsauthor #9
Standardization and Audit of Adverse Drug Reaction Monitoring in Hospital Pharmaceutical Care-In Metabolic Diseases, Nephrology and Endocrinology Ward-
20040 citationsauthor #9
Support System for Pharmaceutical Training in Hospitals Using the Internet and Its Shortcomings
20040 citationsauthor #4
Analysis of information submitted by clinical trial sponsors regarding the safety of investigational drugs.
20041 citationsauthor #10
Investigation of Drugs Contraindicated for Glaucoma Patients, and Rational Use of These Drugs
20040 citationsauthor #10
PCR-based haplotype determination to distinguish CYP2B6*1/*7 and *5/*6.
20044 citationsauthor #6
Frequency Distribution of Thiopurine S-Methyltransferase Activity in Red Blood Cells of a Healthy Japanese Population
200430 citationsauthor #9
Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients
200426 citationsauthor #10
Effect of mixing method on the mixing degree during the preparation of triturations.
20042 citationsauthor #11
Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity.
200416 citationsauthor #4
Items of concern associated with source document verification of clinical trials for new drugs.
20042 citationsauthor #9
Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers
2003209 citationsauthor #10
Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population.
200321 citationsauthor #5
Effects of CYP2D6 Genotypes on Plasma Concentrations of Risperidone and Enantiomers of 9‐Hydroxyrisperidone in Japanese Patients with Schizophrenia
200344 citationsauthor #5
Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide
200313 citationsauthor #9
[Pharmacokinetic/pharmacodynamic analysis of anti-hyperprolactinemic effect of terguride based on dopamine D2 receptor occupancy].
20032 citationsauthor #6
Potentiation of domperidone‐induced catalepsy by a P‐glycoprotein inhibitor, cyclosporin A
200330 citationsauthor #9
Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects
200367 citationsauthor #8
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.
200317 citationsauthor #13
[Investigation of the cause of polyurethane catheter cracking during constant infusion of etoposide (VP-16) injection (2)--Analysis of ethanol eluting materials from catheter].
200311 citationsauthor #8
Combined Therapy Using Q‐Switched Ruby Laser and Bleaching Treatment With Tretinoin and Hydroquinone for Acquired Dermal Melanocytosis
200337 citationsauthor #12
Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With Schizophrenia
200355 citationsauthor #8
Adsorption of rhG-CSF (Filgrastim) to Extension Tube
20033 citationsauthor #4
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2‐receptor occupancy of bromocriptine, of bromocriptine‐induced contralateral rotations in unilaterally 6‐OHDA‐lesioned rats
200310 citationsauthor #8
[The effects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic stem cell transplantation].
200312 citationsauthor #9
Clinical Trial of Bleaching Treatment With 10% All‐Trans Retinol Gel
200325 citationsauthor #9
Sex differences in the pharmacokinetics of pioglitazone in rats.
200351 citationsauthor #7
[Creation and usefulness of the "drug information card" for support of dispensing].
20030 citationsauthor #8
[Documents for clinical trials of new drugs: results of their reviews prior to submissions to IRB].
20030 citationsauthor #6
治験（臨床試験）の事前審査における検討内容の解析
20031 citationsauthor #6
CYP3A4*18: it is not rare allele in Japanese population.
200331 citationsauthor #9
[Evaluation of the permeability of corticosteroid in hairless mouse and hairless micropig skin from admixture of commercially available corticosteroid ointments and/or creams].
20024 citationsauthor #5
Cosmetic Color Improvement of the Nipple‐Areola Complex by Optimal Use of Tretinoin and Hydroquinone
200212 citationsauthor #9
Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D2 receptor occupancy
200224 citationsauthor #9
A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.
20025 citationsauthor #6
Calcium channel blockers and myocardial infarction: a case–control study in a Japanese hospital
20026 citationsauthor #6
Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.
200230 citationsauthor #7
[Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity].
200210 citationsauthor #8
A Survey of the Attitude of the New Graduate Pharmacists on Clinical Trials
20021 citationsauthor #6
[The construction and evaluation of the preventing method for the input mischoice in a prescription order entry system--usefulness of a three-character input and a warning screen display system].
20025 citationsauthor #9
Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes.
200220 citationsauthor #7
Effects of single and repeated treatment with itraconazole on the pharmacokinetics of midazolam in rats.
20023 citationsauthor #5
Development and Evaluation of a Medication Management System for Rational Inventory Control of Medicine.
20012 citationsauthor #7
Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
200190 citationsauthor #11
Guidance on Drug Interaction Studies —From the Standpoint of Clinical Field and Science—
20010 citationsauthor #1
Importance of Pharmaceutical Care Training for Medical Graduate Students as Part of the Bedside Teaching(BST) Program at the Hospital Pharmacy
20010 citationsauthor #8
[Effect of mouth wash on the removing fluticasone propionate delivered by dry powder inhaler in mouth].
200112 citationsauthor #5
Usefulness of a Narrow-Band Reflectance Spectrophotometer in Evaluating Effects of Depigmenting Treatment
200139 citationsauthor #6
P-320 The Comparisons of Management of Outpatient's Prescriptions from Medical Institute to Community Pharmacy in the Separation of Prescriptions and Dispensing (Bunup) between Korea and Japan
20010 citationsauthor #6
Frequency Distribution of CYP2C19, CYP2D6, and CYP2C9 Mutant-alleles in Several Different Populations
200114 citationsauthor #3
Clinical Application of Pharmacokinetics/Pharmacodynamics —From Animal to Human, and Normal to Disease
20010 citationsauthor #1
Questionnaire on the Maintenance of the Clinical Trials Enforcement Organization in University Hospitals
20010 citationsauthor #4
INVOLVEMENT OF CYP 2 B 6 IN N-DEMETHYLATION OF KETAMINE IN HUMAN LIVER MICROSOMES
200116 citationsauthor #7
Quantitative Analysis of Effect of Mixing Condition on Mixing Degree of Powders. II. Inter-Individual Variation and Degree of Dispensing Experience as a Factor of Variation.
20011 citationsauthor #7
[Other drugs administered with TPN solution].
20010 citationsauthor #2
[Analysis of 5-HT3 receptor antagonist, ramosetron hydrochloride, based on receptor occupancy considering its active metabolite].
200114 citationsauthor #6
[Development of an inspection-supporting system using drug images for unit dose packages].
20012 citationsauthor #8
A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs.
200115 citationsauthor #5
P-319 The Changes of Pharmaceutical Services in the Department of Pharmacy after the Separation of Prescriptions and Dispensing (Bunup) in Korea
20010 citationsauthor #5
Quantitative Relationship Between Myocardial Concentration of Tacrolimus and QT Prolongation in Guinea Pigs: Pharmacokinetic/Pharmacodynamic Model Incorporating a Site of Adverse Effect
200151 citationsauthor #6
Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
2001185 citationsauthor #7
Investigation of the Timing of Drug Intake Described in Package Inserts and Their Assessment with Respect to Rational Usage of Medicine
20001 citationsauthor #7
FROM THE STANDPOINT OF CLINICAL FIELD AND SCIENCE
20000 citationsauthor #1
Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver.
200040 citationsauthor #7
Drug Interactions for Labeling: Hospital Pharmacy Perspectives
20000 citationsauthor #2
Influence of blood sampling sites on measurement of blood cyclosporine concentration.
20004 citationsauthor #6
Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats
200097 citationsauthor #7
Experience with a Strong Bleaching Treatment for Skin Hyperpigmentation in Orientals
200055 citationsauthor #4
Medication Information to Be Given to Outpatients : Study on Constructing a System for Accurate Communication of Information
20000 citationsauthor #4
Reflection of Pharmacokinetic study on Package Insert
20000 citationsauthor #1
Evaluations of the prescription order entry system for outpatient clinics by physicians in the 80 university hospitals in Japan
200011 citationsauthor #4
Stereoselective high-performance liquid chromatographic determination of ketamine and its active metabolite, norketamine, in human plasma.
200045 citationsauthor #7

TIMELINE

1970 18 citations

1971 30 citations

1972 4 citations

1973 4 citations

1976 45 citations

1977 9 citations

1978 19 citations

1979 14 citations

1980 16 citations

1981 82 citations

1982 170 citations

1983 132 citations

1984 420 citations

1985 413 citations

1986 201 citations

1987 159 citations

1988 362 citations

1989 144 citations

1990 138 citations

1991 55 citations

1992 254 citations

1993 164 citations

1994 91 citations

1995 165 citations

1996 208 citations

1997 402 citations

1998 333 citations

1999 229 citations

2000 399 citations

2001 441 citations

2002 120 citations

2003 639 citations

2004 224 citations

2005 75 citations

2006 86 citations

2007 43 citations

2010 3 citations

T. Iga

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT